Echavarria-Correa Susan M, Obispo-Achallma Daisy, Espetia Anco Susan, Guevara Maria Luisa, Acosta Conchucos Oscar, Dedios María Isabel, Mamani Zapana Enrique, Fujita Alarcón Ricardo, Yabar Carlos Augusto
Laboratorio de Virología Clínica y Molecular, Facultad de Ciencias Biológicas, Universidad Nacional Mayor de San Marcos, Lima, Peru.
Laboratorio de Referencia Nacional de Virus de Transmisión Sexual, Instituto Nacional de Salud, Lima, Peru.
Hum Genome Var. 2025 Aug 26;12(1):15. doi: 10.1038/s41439-025-00321-3.
Little information is available about CCR5-Δ32 and HLA-B57:01 alleles in the Peruvian population, especially in human immunodeficiency virus (HIV)-negative people with high-risk sexual behavior. Here we describe the prevalence of these alleles in HIV-exposed seronegative individuals (PS) and HIV-seropositive individuals (PVV). For this purpose, 300 individuals were recruited: 150 from each group, and the selected alleles were characterized by endpoint PCR, real-time PCR and DNA sequencing. According to our results, the prevalence of CCR5/CCR5-Δ32 heterozygous was 2.7%, and no homozygous cases were found. The population was in Hardy-Weinberg equilibrium for the CCR5 locus. Regarding HLA-B57:01, one case was identified in the PS group, while no cases were observed in the PVV group. No statistical difference was detected between groups (P > 0.05). In conclusion, we showed a low prevalence for CCR5-Δ32 as HLA-B57:01 in the Peruvian population. As these alleles were found at similar frequencies among both HIV-positive and HIV-negative Peruvian individuals with high-risk sexual behavior, it is possible that other genetic factors play an important role in preventing HIV transmission in this population. The low frequency of the HLA-B57:01 allele in the Peruvian population suggests that routine genotyping tests for abacavir hypersensitivity should be reevaluated in the public health policies of Peru's Ministry of Health, based on national epidemiological data.
关于秘鲁人群中CCR5-Δ32和HLA-B57:01等位基因的信息很少,尤其是在有高危性行为的人类免疫缺陷病毒(HIV)阴性人群中。在此,我们描述了这些等位基因在HIV暴露血清阴性个体(PS)和HIV血清阳性个体(PVV)中的流行情况。为此,招募了300名个体:每组150名,通过终点PCR、实时PCR和DNA测序对选定的等位基因进行特征分析。根据我们的结果,CCR5/CCR5-Δ32杂合子的流行率为2.7%,未发现纯合子病例。CCR5基因座的人群处于哈迪-温伯格平衡状态。关于HLA-B57:01,在PS组中鉴定出1例,而在PVV组中未观察到病例。两组之间未检测到统计学差异(P>0.05)。总之,我们发现秘鲁人群中CCR5-Δ32和HLA-B57:01的流行率较低。由于在有高危性行为的秘鲁HIV阳性和HIV阴性个体中发现这些等位基因的频率相似,因此其他遗传因素可能在该人群预防HIV传播中起重要作用。秘鲁人群中HLA-B57:01等位基因的低频率表明,应根据国家流行病学数据,在秘鲁卫生部的公共卫生政策中重新评估阿巴卡韦超敏反应的常规基因分型检测。